Oracle
ORCL
Apple
AAPL
D.R. Horton
DHI
Adobe
ADBE
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
LGNYZ LIGAND PHARMACEUTICAL INC
- 0.016
- 0.0000.00%
15min DelayClose Feb 21 11:07 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.016Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.01952wk High0.00P/B0Float Cap0.00352wk Low--Dividend TTM0Shs Float0.019Historical High--Div YieldTTM0.00%Amplitude0.003Historical Low--Avg Price1Lot Size
About LIGAND PHARMACEUTICAL INC Company
Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in Jupiter, FL.
Company Profile
SymbolLGNYZ
Company NameLIGAND PHARMACEUTICAL INC
Listing DateNov 17, 1992
Founded1987
MarketPink Market
Address555 Heritage Drive,Suite 200
CityJupiter
ProvinceFlorida
CountryUnited States of America
Zip Code33458
Phone1-858-550-7500
Websitehttp://www.ligand.com
Company Executives
No Data
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.